TEC
AGN

Tiger Eye Capital’s Allergan plc AGN Stock Holding History

Tiger Eye Capital’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-119,708
Closed -$32.5M – 44
2015
Q3 		$32.5M Sell
119,708
-181,910
-60% -$55.9M 4.44% 9
2015
Q2 		$91.5M Buy
301,618
+34,900
+13% +$10.4M 6.73% 1
2015
Q1 		$79.4M Buy
266,718
+111,544
+72% +$31.8M 6.29% 1
2014
Q4 		$39.9M Buy
155,174
+97,474
+169% +$24.4M 3.17% 13
2014
Q3 		$13.9M Sell
57,700
-75,200
-57% -$16.8M 1.4% 30
2014
Q2 		$29.6M Buy
132,900
+1,038
+0.8% +$215K 3.11% 15
2014
Q1 		$27.1M Buy
+131,862
New +$26.1M 4.03% 7

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Tiger Eye Capital's AGN Position: Q4 2015 in Review

Tiger Eye Capital sold out of Allergan plc (AGN) in Q4 2015, closing a stake of 119,708 shares — an estimated $32.5M sold.

Tiger Eye Capital first reported a position in AGN in Q1 2014 and held it in 7 quarters. The position peaked at $91.5M in Q2 2015. 1,110 funds tracked by Wall St. Rank hold AGN as of Q4 2015.

  • Tiger Eye Capital reported no remaining Allergan plc position as of Q4 2015 after selling out during the quarter.
  • Tiger Eye Capital sold 119,708 Allergan plc shares in Q4 2015, an estimated $32.5M.
  • Tiger Eye Capital first reported a position in Allergan plc in Q1 2014 and held it in 7 quarters.
  • Tiger Eye Capital's Allergan plc position peaked at $91.5M in Q2 2015.
  • 1,110 funds tracked by Wall St. Rank held Allergan plc as of Q4 2015.

Based on Tiger Eye Capital's 13F filing for Q4 2015, filed 16 Feb 2016.